secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0001171843-23-001806
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics reports flat FY2022 revenue; net loss widens to $0.19/sh; declares $0.07 dividend
--------------------------------------------------------------------------------

- FY2022 revenue $25.2M (+1% YoY); net loss $1.1M or ($0.19) diluted EPS vs loss $0.7M ($0.12) prior year.
- Q4 2022 revenue $5.7M (-11% YoY); net loss $0.7M or ($0.12) diluted EPS vs loss $1.6M ($0.29).
- Board declared $0.07 quarterly cash dividend, payable April 10, 2023 to holders of record March 31, 2023.
- Cash $4.8M, working capital $4.3M at year-end; equipment financing reduced to $0.6M.
- Management cites labor shortage and inflation challenges; domestic revenue up 4% in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184323001806/0001171843-23-001806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184323001806/f8k_032123.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-001806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer